NSCLC (advanced Non Small Cell Lung Cancer)

AUG 13, 2026 · PHASE 3 TRIAL

Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation

ClinicalTrials.gov

This is a Phase 3 RCT registration with no posted results; the study is actively recruiting and outcomes are not yet reported.

AUG 11, 2026 · PHASE 2 TRIAL

Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC

ClinicalTrials.gov

Phase 2 trial with surrogate endpoint (ORR) in a small, single-arm population; results not yet reported in this registry record.

AUG 3, 2026 · PHASE 2 TRIAL

Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK201 for Injection in Combination With Ivonescimab Injection in sqNSCLC Participants.

ClinicalTrials.gov

This is a Phase 2 trial registration with no posted results; the study is not yet recruiting and planned enrollment is modest, making it too early to assess efficacy or safety.